FOLFOX-bevacizumab chemotherapy in patients with progressive metastatic neuroendocrine tumors

被引：0
|
作者：
Lacombe, C. [1 ]
Perrier, M. [2 ]
Hentic, O. [1 ]
Brixi, H. [2 ]
Rebours, V [1 ]
Cadiot, G. [2 ]
Ruszniewski, P. [1 ]
de Mestier, L. [1 ]
机构：
[1] Univ Paris, Beaujon Hosp, APHP Nord, Dept Gastroenterol Pancreatol, Clichy, France
[2] Univ Reims, Robert Debre Hosp, Dept Hepatogastroenterol & Digest Oncol, Reims, France
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2022年 / 34卷
关键词：
neuroendocrine tumor; antiangiogenic therapy; vegf; well-differentiated;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I17
引用
收藏
页码：179 / 179
页数：1
相关论文
共 50 条
  • [11] Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX-Bevacizumab or FOLFIRI-Bevacizumab: Results From ARIES, a Bevacizumab Observational Cohort Study
    Bendell, Johanna C.
    Beikaii-Saab, Tanios S.
    Cohn, Allen L.
    Hurwitz, Herbert I.
    Kozloff, Mark
    Tezcan, Haluk
    Roach, Nancy
    Mun, Yong
    Fish, Susan
    Flick, E. Dawn
    Dalal, Darshan
    Grothey, Axel
    ONCOLOGIST, 2012, 17 (12): : 1486 - 1495
  • [12] Outcome Analysis of FOLFOX Chemotherapy Treatment in Metastastatic Neuroendocrine Tumors
    Oziel-Taieb, S.
    Cavaglione, G.
    Mineur, L.
    Zemmour, C.
    Faure, M.
    Charrier, N.
    Piana, G.
    Poizat, F.
    Niccoli, P.
    NEUROENDOCRINOLOGY, 2019, 108 : 156 - 156
  • [13] FOLFOX in Neuroendocrine Tumors
    Faure, M.
    Raoul, J. L.
    Autret, A.
    Mineur, L.
    Boustany, R.
    Cavaglione, G.
    Niccoli, P.
    NEUROENDOCRINOLOGY, 2016, 103 : 67 - 67
  • [14] A phase II trial of atezolizumab and bevacizumab in patients with advanced, progressive neuroendocrine tumors (NETs)
    Halperin, Daniel M.
    Liu, Suyu
    Dasari, Arvind
    Fogelman, David R.
    Bhosale, Priya
    Mahvash, Armeen
    Dervin, Shannon
    Estrella, Jeannelyn
    Cortazar, Patricia
    Maru, Dipen M.
    Mckenna, Edward Francis
    Wistuba, Ignacio Ivan
    Schulze, Katja
    Futreal, Phillip Andrew
    Darbonne, Walter C.
    Yun, Cindy
    Hwu, Patrick
    Yao, James C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [15] Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study
    Lievre, Astrid
    Samalin, Emmanuelle
    Mitry, Emmanuel
    Assenat, Eric
    Boyer-Gestin, Christine
    Lepere, Celine
    Bachet, Jean-Baptiste
    Portales, Fabienne
    Vaillant, Jean-Nicolas
    Ychou, Marc
    Rougier, Philippe
    BMC CANCER, 2009, 9 : 347
  • [16] Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study
    Astrid Lièvre
    Emmanuelle Samalin
    Emmanuel Mitry
    Eric Assenat
    Christine Boyer-Gestin
    Céline Lepère
    Jean-Baptiste Bachet
    Fabienne Portales
    Jean-Nicolas Vaillant
    Marc Ychou
    Philippe Rougier
    BMC Cancer, 9
  • [17] Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy
    Cybulska-Stopa, Bozena
    Lugowska, Iwona
    Wisniowski, Rafal
    Domagala-Haduch, Malgorzata
    Rajczykowski, Marcin
    Piejko, Karolina
    Bar-Letkiewicz, Ilona
    Suwinski, Rafal
    Regulski, Krzysztof
    Mackiewicz, Jacek
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2020, 24 (01): : 34 - 41
  • [18] Chemotherapy in Patients with Progressive, Undifferentiated Neuroendocrine Tumors: A Single-Center Experience
    Deutschbein, T.
    Unger, N.
    Yuece, A.
    Eberhardt, W.
    Gauler, T.
    Lahner, H.
    Mann, K.
    Petersenn, S.
    HORMONE AND METABOLIC RESEARCH, 2011, 43 (12) : 838 - 843
  • [19] Bevacizumab and Subtype-Adapted Chemotherapy Backbone in Neuroendocrine Tumors
    Hadoux, Julien
    Ducreux, Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (07) : 976 - 977
  • [20] FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study
    Torregrosa, Cecile
    Pernot, Simon
    Vaflard, Pauline
    Perret, Audrey
    Tournigand, Christophe
    Randrian, Violaine
    Doat, Solene
    Neuzillet, Cindy
    Moulin, Valerie
    Stouvenot, Morgane
    Roth, Gael
    Darbas, Tiffany
    Auberger, Benjamin
    Godet, Tiphaine
    Jaffrelot, Marion
    Lambert, Aurelien
    Dubreuil, Olivier
    Gluszak, Cassandre
    Bernard-Tessier, Alice
    Turpin, Anthony
    Palmieri, Lola-Jade
    Bouche, Olivier
    Goujon, Gael
    Lecomte, Thierry
    Sefrioui, David
    Locher, Christophe
    Grados, Lucien
    Gignoux, Pauline
    Trager, Stephanie
    Nassif, Elise
    Saint, Angelique
    Hammel, Pascal
    Lecaille, Cedric
    Bureau, Mathilde
    Perrier, Marine
    Botsen, Damien
    Bourgeois, Vincent
    Taieb, Julien
    Auclin, Edouard
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (11) : 1978 - 1988
12345